Skip to content

Impact of Sperm DNA Integrity on In Vitro Cycles

Impact of Sperm DNA Integrity on In Vitro Cycles

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01232465
Acronym
TBA on IVF
Enrollment
420
Registered
2010-11-02
Start date
2010-10-31
Completion date
2013-09-30
Last updated
2014-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Habitual, Male Infertility, Unexplained Infertility

Keywords

sperm DNA integrity, Toluidine blue assay (TBA), IVF outcome

Brief summary

Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.

Interventions

None listed

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* couple undergoing IVF at the Center for Human Reproduction * sperm sample given from partner (not a donor)

Exclusion criteria

* low sperm concentration (\<5 million/cc) * using a donor sample

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy9 monthsdetemining whether the sperm sample (tested for DNA integrity) used to insemenate IVF retrieved eggs, results in a live birth

Countries

United States

Participant flow

Recruitment details

Recruitment occured at the Center for Human Reproduction under an IRB waiver of informed consent for participation.

Participants by arm

ArmCount
IVF Cycles
those individuals undergoing conventional IVF to inseminate their retrieved eggs
337
ICSI
those individuals whose eggs were fertilized via intracytoplasmic sperm injection (ICSI)
402
Total739

Baseline characteristics

CharacteristicICSIIVF CyclesTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
402 Participants337 Participants739 Participants
Age, Continuous34.9 years
STANDARD_DEVIATION 2.5
34.7 years
STANDARD_DEVIATION 2.6
34.8 years
STANDARD_DEVIATION 2.6
Region of Enrollment
United States
402 participants337 participants739 participants
Sex: Female, Male
Female
402 Participants337 Participants739 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Pregnancy

detemining whether the sperm sample (tested for DNA integrity) used to insemenate IVF retrieved eggs, results in a live birth

Time frame: 9 months

ArmMeasureValue (NUMBER)
IVF CyclesPregnancy67 participants
ICSIPregnancy80 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026